8-cyclopentyl-3-(3-((4-(fluorosulfonyl)benzoyl)oxy)propyl)-1-propylxanthine has been researched along with 4-nitrobenzylthioinosine in 4 studies
| Studies (8-cyclopentyl-3-(3-((4-(fluorosulfonyl)benzoyl)oxy)propyl)-1-propylxanthine) | Trials (8-cyclopentyl-3-(3-((4-(fluorosulfonyl)benzoyl)oxy)propyl)-1-propylxanthine) | Recent Studies (post-2010) (8-cyclopentyl-3-(3-((4-(fluorosulfonyl)benzoyl)oxy)propyl)-1-propylxanthine) | Studies (4-nitrobenzylthioinosine) | Trials (4-nitrobenzylthioinosine) | Recent Studies (post-2010) (4-nitrobenzylthioinosine) |
|---|---|---|---|---|---|
| 28 | 0 | 12 | 666 | 2 | 57 |
| Protein | Taxonomy | 8-cyclopentyl-3-(3-((4-(fluorosulfonyl)benzoyl)oxy)propyl)-1-propylxanthine (IC50) | 4-nitrobenzylthioinosine (IC50) |
|---|---|---|---|
| Equilibrative nucleoside transporter 1 | Homo sapiens (human) | 0.0043 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
| Gesztelyi, R; Haines, DD; Juhasz, B; Kiss, Z; Pak, K; Szentmiklosi, AJ; Tosaki, A; Varga, B; Zsuga, J | 1 |
| Erdei, T; Gesztelyi, R; Juhasz, B; Lampe, N; Papp, C; Pinter, A; Szabó, K; Szentmiklosi, AJ; Szilvássy, Z; Zsuga, J | 1 |
4 other study(ies) available for 8-cyclopentyl-3-(3-((4-(fluorosulfonyl)benzoyl)oxy)propyl)-1-propylxanthine and 4-nitrobenzylthioinosine
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
The guinea pig atrial A1 adenosine receptor reserve for the direct negative inotropic effect of adenosine.
Topics: Adenosine; Adenosine A1 Receptor Antagonists; Animals; Atrial Function; Dose-Response Relationship, Drug; Guinea Pigs; Heart Atria; In Vitro Techniques; Male; Myocardial Contraction; Receptor, Adenosine A1; Thioinosine; Xanthines | 2013 |
Methodical Challenges and a Possible Resolution in the Assessment of Receptor Reserve for Adenosine, an Agonist with Short Half-Life.
Topics: Adenosine; Animals; Biological Transport; Computer Simulation; Equilibrative Nucleoside Transporter 1; Guinea Pigs; Half-Life; Kinetics; Models, Statistical; Myocardium; Myocytes, Cardiac; Purinergic P1 Receptor Antagonists; Receptor, Adenosine A1; Thioinosine; Xanthines | 2017 |